Related Experiment Videos

5-Lipoxygenase activation by MAPKAPK-2 and ERKs

Oliver Werz¹, Eva Bürkert, Lutz Fischer

¹Institute of Pharmaceutical Chemistry, University of Frankfurt, Germany.

Advances in Experimental Medicine and Biology

|May 20, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Control of Gemcitabine Activity With Blue and Red Light.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026

First Structure-Activity-Relationship Study of Potent G2A Antagonists.

Journal of medicinal chemistry·2026

Radioiodination of Two Carborane-Based Dual Cyclooxygenase-2/5-Lipoxygenase Inhibitors and Their In Vitro and In Vivo Evaluation.

Chembiochem : a European journal of chemical biology·2026

Exploiting the 2-(1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic Acid Scaffold to Generate COXTRANs: A New Class of Dual Cyclooxygenase Inhibitors-Thromboxane Receptor Antagonists.

Journal of medicinal chemistry·2025

Control of ALOX5 expression in monocytic cells using a synthetic riboswitch.

Biochimica et biophysica acta. Molecular and cell biology of lipids·2025

Coactosin-Like Protein Reduces Prostaglandin D2 Production in Alveolar Macrophages and Alleviates Allergic Airway Inflammation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

See all related articles